Subscribe
shutterstock_2055997766_michael_vi
Michael Vi / Shutterstock.com
25 May 2023Big PharmaLiz Hockley

J&J settles Amgen clash over blockbuster psoriasis drug

Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
J&J hit with suit over Neutrogena products
20 April 2023   Canadian firm alleges infringement of patent directed to cosmetic and pharmaceutical formulations | Pharma giant declined a licensing agreement.
Americas
Eye care company settles with J&J Surgical Vision for $199m
13 February 2023   J&J had accused defendant of infringing patents related to cataract surgery | Company also complained its copyright-protected computer programs had been ripped off, alleging “piracy of a nearly unfathomable scale”.
article
J&J awarded $18m in fake surgical devices case
27 July 2023   Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
J&J hit with suit over Neutrogena products
20 April 2023   Canadian firm alleges infringement of patent directed to cosmetic and pharmaceutical formulations | Pharma giant declined a licensing agreement.
Americas
Eye care company settles with J&J Surgical Vision for $199m
13 February 2023   J&J had accused defendant of infringing patents related to cataract surgery | Company also complained its copyright-protected computer programs had been ripped off, alleging “piracy of a nearly unfathomable scale”.
article
J&J awarded $18m in fake surgical devices case
27 July 2023   Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.

More on this story

Big Pharma
J&J hit with suit over Neutrogena products
20 April 2023   Canadian firm alleges infringement of patent directed to cosmetic and pharmaceutical formulations | Pharma giant declined a licensing agreement.
Americas
Eye care company settles with J&J Surgical Vision for $199m
13 February 2023   J&J had accused defendant of infringing patents related to cataract surgery | Company also complained its copyright-protected computer programs had been ripped off, alleging “piracy of a nearly unfathomable scale”.
article
J&J awarded $18m in fake surgical devices case
27 July 2023   Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages